Edition:
United States

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.83USD
2:36pm EDT
Change (% chg)

$-0.04 (-4.55%)
Prev Close
$0.87
Open
$0.87
Day's High
$0.87
Day's Low
$0.82
Volume
148,997
Avg. Vol
155,828
52-wk High
$3.65
52-wk Low
$0.82

RGLS.OQ

Chart for RGLS.OQ

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.63
Market Cap(Mil.): $90.29
Shares Outstanding(Mil.): 103.79
Dividend: --
Yield (%): --

Financials

  RGLS.OQ Industry Sector
P/E (TTM): -- 79.67 32.70
EPS (TTM): -1.53 -- --
ROI: -95.74 2.87 14.88
ROE: -149.70 5.20 16.12

BRIEF-Growth Equity Opportunities reports 11.3 pct stake in Regulus Therapeutics

* Growth Equity Opportunities V reports 11.3 percent stake in Regulus Therapeutics Inc as of July 24 - SEC filing Source text: (http://bit.ly/2u4yxoS) Further company coverage:

Aug 02 2017

BRIEF-Regulus Therapeutics Q2 loss per share $0.41

* Regulus reports second quarter 2017 financial results and recent events

Aug 01 2017

BRIEF-Broadfin Capital reports 5.65 pct passive stake in Regulus Therapeutics - ‍​SEC filing

* Broadfin Capital LLC reports 5.65 percent passive stake in Regulus Therapeutics Inc as of July 20, 2017 - ‍​SEC filing Source text: (http://bit.ly/2vSFqWv) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Jul 24 2017

BRIEF-Aptuit announces strategic provider agreement with Regulus Therapeutics

* Aptuit announces strategic provider agreement with Regulus Therapeutics Source text for Eikon: Further company coverage:

Jun 08 2017

BRIEF-EcoR1 Capital reports 9.6 pct passive stake in Regulus Therapeutics

* EcoR1 Capital LLLC reports a 9.6 percent passive stake in Regulus Therapeutics Inc as of May 17 - SEC filing Source text for Eikon: (http://bit.ly/2r8sCMk) Further company coverage:

May 30 2017

BRIEF-Regulus reports Q4 loss per share $0.38

* Regulus reports fourth quarter 2016 financial results and pipeline update

Mar 02 2017

Competitors

Earnings vs. Estimates